Juan Miguel
Suárez Rivero
Investigador no período 2018-2022
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (7)
2022
-
UPRmt activation improves pathological alterations in cellular models of mitochondrial diseases
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
2021
-
Down regulation of the expression of mitochondrial phosphopantetheinyl-proteins in pantothenate kinase-associated neurodegeneration: pathophysiological consequences and therapeutic perspectives
Orphanet Journal of Rare Diseases, Vol. 16, Núm. 1
2020
-
Parkin-mediated mitophagy and autophagy flux disruption in cellular models of MERRF syndrome
Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 6
-
Precision Medicine in Rare Diseases
DISEASES, Vol. 8, Núm. 4
2019
-
Pantothenate Rescues Iron Accumulation in Pantothenate Kinase-Associated Neurodegeneration Depending on the Type of Mutation
Molecular Neurobiology, Vol. 56, Núm. 5, pp. 3638-3656
2017
-
Coenzyme Q10 partially restores pathological alterations in a macrophage model of Gaucher disease
Orphanet Journal of Rare Diseases, Vol. 12, Núm. 1, pp. 1-15
-
Dynamic reorganization of the cytoskeleton during apoptosis: The two coffins hypothesis
International Journal of Molecular Sciences, Vol. 18, Núm. 11